Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Jerusalem Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	11.98	11.74	6.59	7.73	5.44
Short-Term Investments	9.88	0.09	0.05	0.03	0.03
Trading Asset Securities	-	-	-	0.03	0.03
Cash & Short-Term Investments	21.85	11.84	6.64	7.79	5.49
Cash Growth	84.62%	78.27%	-14.72%	41.69%	171.63%
Accounts Receivable	35.9	28.25	29.95	31.63	30.81
Other Receivables	-	-	0	-	-
Receivables	35.9	28.25	29.95	31.63	30.81
Inventory	13.05	8.34	10.41	10.88	14.76
Prepaid Expenses	-	0.31	0.51	0.4	0.73
Other Current Assets	2.7	2.8	3.1	2.22	3.33
Total Current Assets	73.5	51.54	50.61	52.91	55.12
Property, Plant & Equipment	28.83	25.9	27.13	25.48	27.47
Long-Term Investments	4.36	7.24	6.42	3.22	0.7
Other Intangible Assets	2.62	1.8	1.55	1.52	3.04
Long-Term Deferred Tax Assets	0.56	0.4	0.28	0.27	0.2
Other Long-Term Assets	2.6	2.27	0.32	0.32	0.37
Total Assets	112.46	89.15	86.32	83.72	86.89
Accounts Payable	5.28	3.29	3.48	6.56	5.11
Accrued Expenses	-	3.58	2.33	1.32	1.99
Short-Term Debt	0.72	0.46	0.52	0.65	0.78
Current Portion of Long-Term Debt	-	0.61	1.13	0.69	0.57
Current Portion of Leases	0.44	0.3	0.48	0.36	0.55
Current Income Taxes Payable	3.51	1.29	2.42	2.67	1.66
Other Current Liabilities	7.26	2.46	1.95	1.46	2.3
Total Current Liabilities	17.2	12	12.32	13.7	12.97
Long-Term Leases	0.16	0.14	0.33	0.49	0.72
Long-Term Unearned Revenue	0.53	0.29	-	-	-
Pension & Post-Retirement Benefits	6.36	5.12	4.79	4.3	4.64
Total Liabilities	24.26	17.55	17.44	18.49	18.32
Common Stock	18	18	18	18	18
Additional Paid-In Capital	3.72	3.72	3.72	3.72	3.72
Retained Earnings	51.63	42.83	39.6	34.9	29.89
Comprehensive Income & Other	13.77	6.04	6.52	7.65	14.87
Total Common Equity	87.12	70.6	67.84	64.27	66.47
Minority Interest	1.08	1.01	1.04	0.96	2.1
Shareholders' Equity	88.2	71.61	68.88	65.23	68.57
Total Liabilities & Equity	112.46	89.15	86.32	83.72	86.89
Total Debt	1.32	1.51	2.47	2.18	2.63
Net Cash (Debt)	20.53	10.32	4.17	5.6	2.86
Net Cash Growth	98.89%	147.75%	-25.64%	95.69%	-
Net Cash Per Share	1.14	0.57	0.23	0.31	0.16
Filing Date Shares Outstanding	18.04	18	18	18	18
Total Common Shares Outstanding	18.04	18	18	18	18
Working Capital	56.29	39.53	38.28	39.2	42.16
Book Value Per Share	4.83	3.92	3.77	3.57	3.69
Tangible Book Value	84.5	68.8	66.29	62.75	63.43
Tangible Book Value Per Share	4.69	3.82	3.68	3.49	3.52
Land	-	9.49	10.63	9.24	8.31
Buildings	-	15.42	15.64	15.73	16.34
Machinery	-	30.8	29.47	28.78	31.82

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.